NORA BETH DORSEY, Chief Special Master.
On June 7, 2016, Christi Jewell ("petitioner") filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,
On July 19, 2016, the staff attorney assigned to manage this case on behalf of the undersigned held the initial telephonic status conference. Paul Brazil appeared for petitioner. Sarah Duncan appeared for respondent. At the conference, respondent's counsel indicated that respondent intended to defend this claim, as respondent believes the onset of petitioner's shoulder injury symptoms was two weeks subsequent to her vaccination and is therefore not temporally appropriate. Sched. Order, issued July 20, 2016 (ECF No. 8).
Respondent filed his Rule 4(c) Report on September 2, 2016. In respondent's view, petitioner had failed to provide "reliable scientific or medical evidence establishing that the time between her Tdap vaccination and the onset of left shoulder pain two weeks later would be considered `medically acceptable to infer causation-in-fact.'" Rule 4(c) Report, filed Sept. 2, 2016 (ECF No 9), at 7 (citing de Bazan v. HHS, 539 F.3d 1347, 1352 (Fed. Cir. 2008)).
Thereafter, the undersigned requested petitioner file an affidavit describing the onset of her injury, as well as updated treatment records. Sched. Order, issued Sept. 8, 2016 (ECF No. 10). After a review of all evidence, including petitioner's updated medical records and affidavit, the undersigned issued an Order urging the parties to informally resolve this claim noting as follows:
Sched. Order, issued Nov. 3, 2016 (ECF No. 14).
On December 1, 2016, the staff attorney assigned to manage this case convened a status conference at respondent's request to schedule a fact hearing. The parties agreed that a fact hearing would be the appropriate next step. Sched. Order, issued Dec. 1, 2016 (ECF No. 15).
Based on the parties' input, the undersigned scheduled a fact hearing for April 27, 2017, in Washington, D.C. See Pre-Hearing Order, issued Jan. 11, 2017 (ECF No. 18). Petitioner filed a witness list on April 13, 2017. (ECF No. 22). Respondent did not plan to call any witnesses. Informal Communicated dated April 14, 2017.
The undersigned held the fact hearing as planned, with petitioner and her husband testifying via videoconference.
Subsequent to the hearing, the undersigned convened a status conference with the parties' counsel on May 2, 2017. Sched. Order, issued May 5, 2017 (ECF No. 24). With the agreement of the parties, the undersigned provided her preliminary findings in this claim, and indicated her intent to file the medical journal article, S. Atanasoff et al., Shoulder injury related to vaccine administration (SIRVA), 28 Vaccine 8049 (2010), as Court's Exhibit 1 (hereinafter "Atanasoff"). Id. The undersigned further indicated her intent to issue a written ruling in regard to onset and entitlement, finding petitioner entitled to compensation, subsequent to the filing of the hearing transcript. Id. The parties were ordered to file any additional evidence within thirty days subsequent to the filing of the transcript of the April 27, 2017 Hearing. Id. at 2. The April 27, 2017 Hearing transcript was filed on May 16, 2017. Hearing Transcript ("Tr."), filed May 16, 2017 (ECF No. 26). No additional evidence was filed by either party.
On June 14, 2017, respondent filed a status report indicating that "[i]n light of the Chief Special Master's preliminary findings and conclusions in the May 5, 2017 Scheduling Order, respondent reports that he is interested in pursuing settlement negotiations." Status Report, filed June 14, 2017. (ECF No. 27). Since that time the parties have been engaged in discussions to resolve this claim. Notwithstanding respondent's June 14, 2017 Status Report the undersigned issued an Order on July 26, 2017, reiterating her intent to issue a Ruling on Onset and Entitlement in this claim consistent with her May 5, 2017 Scheduling Order. Order, issued July 26, 2017 (ECF No. 31).
Accordingly, this claim is ripe for a ruling. The undersigned notes that there are two issues to be resolved: (1) the onset of petitioner's symptoms, and (2) whether petitioner sustained a shoulder injury related to vaccine administration ("SIRVA") caused-in-fact by her Tdap vaccination. The undersigned's ruling below is based upon the record as whole, including the filed medical records, the testimony of Mr. and Mrs. Jewell on April 27, 2017, a review of the April 27, 2017 Hearing transcript, and Atanasoff, supra.
With regard to the onset of symptoms, the undersigned finds that petitioner experienced pain within 72 hours subsequent to her February 19, 2015 Tdap vaccination. In making this determination the undersigned relied heavily on petitioner's physical therapy records. In the undersigned's experience physical therapists perform thorough initial evaluations, and follow-up examinations, generally keeping accurate records. In this case, petitioner's physical therapy records note that "she had a tetanus shot on Feb[uary] 19th. After that shot a few days later she started to notice left shoulder pain." Pet Ex. 2 at 231.
With regard to whether petitioner suffered a SIRVA, the undersigned finds that petitioner fulfilled all of the criteria for a Table SIRVA injury except for establishing onset of her injury within 48 hours.
Further, although the undersigned cannot find that petitioner experienced the onset of her shoulder injury within 48 hours as required by the current Table, the undersigned finds that petitioner experienced the onset of her shoulder injury within 72 hours. This is a medically appropriate temporal relationship to her vaccination as evidenced by Atanasoff. Atanasoff found that one of thirteen patients (8 percent) experienced the onset of a shoulder injury related to vaccination at 4 days. Court's Ex. 1 at Table 1 (ECF No. 24-1).
Accordingly, based on all of the above the undersigned then found that petitioner had met her burden of proving causation-in-fact under Althen v. HHS, 418 F.3d 1274 (Fed. Cir. 2005).
82 Fed. Reg. 6303 (Qualifications and Aids to Interpretation for SIRVA); see also National Vaccine Injury Compensation Program: Revisions to the Vaccine Injury Table, 80 Fed. Reg. 45132, Notice of Proposed Rulemaking, July 29, 2015 (citing Atanasoff).